MOVE for Your MIND
Prevention of Cognitive Decline and Falls With Dalcroze Eurhythmics and a Simple Home Exercise Strength Program for Seniors With Subjective Cognitive Decline (SCD) - MOVE for Your MIND
1 other identifier
interventional
195
1 country
1
Brief Summary
Among the most promising interventions targeting both cognitive and functional decline, is Exercise. However, evidence regarding exercise interventions among seniors with cognitive impairment are inconclusive, likely due to challenges of recruitment and adherence. Alternatively, seniors with subjective cognitive decline (SCD), who are not yet meeting objective criteria of cognitive impairment, but have been shown to have twice the conversion rate to dementia compared with healthy seniors, are more likely to be motivated to participate and adhere to exercise interventions. Thus, exercise interventions in seniors with SCD may provide a window of opportunity for early prevention of dementia and falls. The investigators aim to test the effect of a group exercise (multi-task Jaques-Dalcroze Eurhythmics) and a simple home strength exercise program on change of cognitive function and the rate of falling among seniors with SCD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2017
CompletedStudy Start
First participant enrolled
December 14, 2017
CompletedFirst Posted
Study publicly available on registry
December 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2022
CompletedAugust 9, 2024
August 1, 2024
3.9 years
October 16, 2017
August 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in cognitive function
assessed with the CERAD-plus test
12 months
Rate of falls
The circumstances and injuries associated with the fall will be ascertained with a questionnaire.
12 months
Secondary Outcomes (27)
Proportion of seniors with any falls and injurious falls
12 months
Rate of injurious falls
12 months
Cognitive function: verbal fluency test
12 months
Cognitive function: Boston Naming test
12 months
Cognitive function: Mini Mental State Exam
12 months
- +22 more secondary outcomes
Other Outcomes (10)
Structural brain changes
12 months
Daily physical activity
12 months
Effect of life-time physical activity
Baseline
- +7 more other outcomes
Study Arms (3)
Dalcroze Eurhythmics program
ACTIVE COMPARATORmusic-based multi-task exercise intervention
home exercise strength program
ACTIVE COMPARATORsimple strength training program to perform individually at home
Control group
NO INTERVENTIONno change in the daily activities, no exercise intervention
Interventions
music-based multi-task exercise in group setting
simple strength exercise program to perform individually at home
Eligibility Criteria
You may qualify if:
- Age 70+, living in the community
- Meet the criterion for SCD defined by a score of ≥25 points on the MAC-Q questionnaire
You may not qualify if:
- Signs of mild cognitive impairment (MCI), MoCA score ≤24
- Score of ≥5 on the short form of the Geriatric Depression Scale (15items)
- Inability to walk or to come to the study entre
- Severe gait impairment or diseases with a risk of recurrent falling (e.g. Parkinson's disease/syndrome, Hemiplegia after stroke, symptomatic stenosis of the spinal canal, polyneuropathy, epilepsy, recurring vertigo, recurring syncope, heavy alcohol consumption)
- Currently engaged in regular (once a week or more) strength training instructed by a professional teacher and including the explicit aim to improve muscle strength, or regular (once a week or more) Dalcroze eurhythmics classes
- Active cancer or current cancer treatment
- Inability to read and/or speak German necessary to understand the instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Swiss National Science Foundation, Switzerlandcollaborator
- University Hospital, Toulouse, Francecollaborator
- Waid City Hospital, Zurich, Switzerlandcollaborator
- Felix Platter Hospital, Basel, Switzerlandcollaborator
- JungDiagnostics, Hamburg, Germanycollaborator
- Ferrari Data Solutioncollaborator
- Vontobel Foundation, Switzerlandcollaborator
- Age Stiftung, Zurich, Switzerlandcollaborator
- Gemeinnützige Stiftung EMPIRIS, Alzheimer Fund, Zurich Switzerlandcollaborator
- Stiftung für Demenzforschung in Basel, Switzerlandcollaborator
Study Sites (1)
Centre on Aging and Mobility, University of Zurich
Zurich, 8037, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heike A Bischoff, Prof. Dr. med., DrPH
University of Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2017
First Posted
December 27, 2017
Study Start
December 14, 2017
Primary Completion
November 2, 2021
Study Completion
November 2, 2022
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share